These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26545402)

  • 21. Potential impact of USPSTF recommendations on early diagnosis of breast cancer.
    Aragon R; Morgan J; Wong JH; Lum S
    Ann Surg Oncol; 2011 Oct; 18(11):3137-42. PubMed ID: 21947591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammographic density and risk of second breast cancer after ductal carcinoma in situ.
    Habel LA; Capra AM; Achacoso NS; Janga A; Acton L; Puligandla B; Quesenberry CP
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2488-95. PubMed ID: 20929881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How different terminology for ductal carcinoma in situ (DCIS) impacts women's concern and management preferences: A qualitative study.
    Nickel B; Barratt A; Hersch J; Moynihan R; Irwig L; McCaffery K
    Breast; 2015 Oct; 24(5):673-9. PubMed ID: 26376460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ductal carcinoma in situ of the breast. Long-term follow-up of health-related quality of life, emotional reactions and body image.
    Sackey H; Sandelin K; Frisell J; Wickman M; Brandberg Y
    Eur J Surg Oncol; 2010 Aug; 36(8):756-62. PubMed ID: 20598492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparities in reconstruction rates after mastectomy for ductal carcinoma in situ (DCIS): patterns of care and factors associated with the use of breast reconstruction for DCIS compared with invasive cancer.
    Kruper L; Xu X; Henderson K; Bernstein L
    Ann Surg Oncol; 2011 Oct; 18(11):3210-9. PubMed ID: 21863363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
    Kuhl CK; Schrading S; Bieling HB; Wardelmann E; Leutner CC; Koenig R; Kuhn W; Schild HH
    Lancet; 2007 Aug; 370(9586):485-92. PubMed ID: 17693177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen.
    Szynglarewicz B; Kasprzak P; Halon A; Matkowski R
    World J Surg Oncol; 2015 Jul; 13():218. PubMed ID: 26179898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceptions of contralateral breast cancer: an overestimation of risk.
    Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
    Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics associated with upgrading to invasiveness after surgery of a DCIS diagnosed using percutaneous biopsy.
    Hogue JC; Morais L; Provencher L; Desbiens C; Poirier B; Poirier É; Jacob S; Diorio C
    Anticancer Res; 2014 Mar; 34(3):1183-91. PubMed ID: 24596358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms underlying social inequality in post-menopausal breast cancer.
    Hvidtfeldt UA
    Dan Med J; 2014 Oct; 61(10):B4922. PubMed ID: 25283627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
    Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
    Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ.
    Hird RB; Chang A; Cimmino V; Diehl K; Sabel M; Kleer C; Helvie M; Schott A; Young J; Hayes D; Newman L
    Cancer; 2006 May; 106(10):2113-8. PubMed ID: 16596655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eliminating "ductal carcinoma in situ" and "lobular carcinoma in situ" (DCIS and LCIS) terminology in clinical breast practice: The cognitive psychology point of view.
    Pravettoni G; Yoder WR; Riva S; Mazzocco K; Arnaboldi P; Galimberti V
    Breast; 2016 Feb; 25():82-5. PubMed ID: 26614547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
    Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
    Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS).
    Cheung S; Booth ME; Kearins O; Dodwell D
    Breast; 2014 Dec; 23(6):807-11. PubMed ID: 25270228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of local recurrence following excision alone for ductal carcinoma in situ.
    Hetelekidis S; Collins L; Silver B; Manola J; Gelman R; Cooper A; Lester S; Lyons JA; Harris JR; Schnitt SJ
    Cancer; 1999 Jan; 85(2):427-31. PubMed ID: 10023711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40).
    von Minckwitz G; Darb-Esfahani S; Loibl S; Huober J; Tesch H; Solbach C; Holms F; Eidtmann H; Dietrich K; Just M; Clemens MR; Hanusch C; Schrader I; Henschen S; Hoffmann G; Tiemann K; Diebold K; Untch M; Denkert C
    Breast Cancer Res Treat; 2012 Apr; 132(3):863-70. PubMed ID: 21667238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.